BPC-157 dosing at telos rx is always set by a licensed provider after reviewing your intake at telosrx.com. The plan is based on your history and goals, not a fixed number pulled from a forum. This article covers the general principles behind dosing decisions, not a specific amount to use on your own.
There is no single BPC-157 dose that fits everyone. Your provider sets an amount and schedule based on your intake, and can adjust it as you go. Do not copy a dose you saw online or from a friend's protocol. What worked for someone else may not be appropriate for your history.
Start your intake →Why there is no universal dose
BPC-157 dosing depends on several individual factors. These include what you are using it for, your general health history, and how you respond over the first few weeks. A provider weighs all of this together rather than applying one figure to every patient.
Compounded BPC-157 is not FDA-approved, and there is no manufacturer label with a standardized dosing chart the way there is for many long-established medications. That makes provider judgment, not a printed number, the actual source of your dosing plan.
Any dosing decision, including your starting amount and any later change, is subject to medical approval by a licensed provider. This is true even if you have used BPC-157 before with a different provider.
How providers typically approach a starting point
Providers generally favor starting conservatively and adjusting from there, rather than beginning at a higher amount and hoping it goes well. This approach lets your provider watch how you tolerate the medication before increasing anything.
Your intake at telos rx asks about your health history, current medications, and what you hope to use BPC-157 for. That information shapes the starting point your provider recommends. Two patients with different goals may end up on different plans even if their overall health looks similar on paper.
Once you are approved, your care team can answer specific questions about your prescription through messaging. This article describes the general decision-making process. It is not a substitute for what your provider tells you directly about your own plan.
Key takeaway: Dosing is individualized and provider-led, not a fixed number you can find online. Your history, goals, and response over time all factor into what your provider recommends.
Why some patients see dose adjustments over time
It is common for a provider to revisit your dose after the first few weeks. By then there is more information about how you are responding. This is a normal part of ongoing care, not a sign that the initial plan was wrong.
Quarterly labs, included with your plan, give your provider objective information alongside what you report. Together these help your provider decide whether to hold steady, adjust the amount, or change the schedule.
If you feel your current plan is not right for you, tell your care team rather than adjusting on your own. Message them through your account and describe specifically what you are noticing, since vague feedback is harder to act on than specific detail.
Reconstitution and preparation, in general terms
Depending on how your prescription is prepared, you may need to combine components before use, or you may receive a ready-to-use solution. Either way, your provider or care team explains what your specific vial requires.
This article intentionally does not provide a mixing ratio or a specific volume to draw up. Those details vary by prescription and should come from your provider, not from a general article. Asking your care team directly is always the safer path.
Keep any written instructions your provider gives you in an easy-to-find place, and refer back to them rather than relying on memory alone, especially in your first few weeks.
Schedule and frequency considerations
How often BPC-157 is used varies by patient and by what it is being used for. Some patients are on a daily schedule, others less frequently. Your provider determines this as part of your overall plan rather than it being a fixed industry standard.
Consistency in timing tends to matter more than the exact hour of day. Picking a routine that fits your schedule, and sticking with it, is usually more useful than chasing an optimal time that is hard to maintain.
If your schedule changes, for example a new job or travel, tell your care team so they can help you adjust your routine rather than skipping doses without a plan.
What a thinner evidence base means for dosing
BPC-157 has a considerably thinner published evidence base in humans than long-established medications with decades of large-scale study behind them. Early research and laboratory work have explored a proposed mechanism, but there is not a large body of controlled human dosing trials to draw a single standard from.
This is one reason provider judgment plays such a central role. Rather than reading from an established dosing chart, your provider is drawing on clinical experience and your individual case. Ask your provider directly what is known and what remains an open question if you want that context.
For general background on how the FDA regulates compounded medication like BPC-157, see the FDA overview of drug compounding. For general NIH health information resources, see the NIH NIDDK health information library, which does not specifically cover BPC-157 but explains how NIH organizes consumer health topics.
How intake and approval work
Starting with telos rx begins with an asynchronous intake, typically about five minutes, with no appointment required. A US-licensed provider reviews your answers, often within hours, and decides on an appropriate plan including your starting dose.
Approval is not guaranteed. A provider may decline treatment or suggest a different path depending on your history, and if you are declined you pay nothing. Start your intake to see what your provider recommends for you specifically.
Pricing for BPC-157 through telos rx is as low as $116 per month, and plans include unlimited messaging, quarterly labs, dose adjustments, and free 2-day shipping. You can cancel anytime with no fee.
If your dosing questions come up after your first shipment arrives, your existing plan already includes the support to handle them. There is no separate fee for messaging your provider about a dosing concern, and no limit on how often you can ask.
Signs your dose may need attention
Message your care team if you notice a new or worsening reaction near an injection site. The same goes if something about your routine feels consistently off after the first couple of weeks. Early feedback helps your provider fine tune your plan sooner rather than later.
It is also worth reaching out if life circumstances change, for example a new medication prescribed by another doctor, since that can affect what your provider recommends going forward.
None of this requires waiting for a scheduled appointment. Messaging is unlimited and asynchronous, so you can raise a concern the moment it comes up rather than sitting on it.
Combining BPC-157 with other protocols
Some patients are also considering other peptides such as sermorelin or NAD nasal spray alongside BPC-157. If that describes you, mention it during intake so your provider can consider your full picture rather than evaluating BPC-157 in isolation.
Combining protocols is a decision for your provider to make with you, not something to assemble independently based on what other people are doing. Your history is the deciding factor, not a general pairing you read about.
Begin your evaluation and raise any other protocols you are using or considering during your intake.
Tracking your response between check-ins
Keeping a simple note of what you notice week to week gives your provider more to work with than a general impression at your next check-in. You do not need anything elaborate, just a short entry each week covering how you feel and anything unusual.
Bring specifics rather than generalities when you message your care team. Saying that tenderness at the injection site has increased since a specific day is far more useful than saying you are not sure it is working. Specific notes let your provider respond with something concrete.
Your quarterly labs add another layer to this picture. Between labs, your own notes are the main source of information your provider has, so a little consistency on your end goes a long way toward a plan that actually fits you.
What to avoid doing on your own
- Copying a dose or schedule you saw recommended online without provider input.
- Increasing your dose because results feel slow, without checking with your care team first.
- Mixing your own reconstitution ratio instead of following what your provider specifies.
- Skipping quarterly labs because you feel fine.
- Starting a second peptide protocol without mentioning it to your provider.
Each of these shortcuts removes the provider oversight that dosing decisions are built around, and that oversight is the actual safety mechanism behind a personalized plan.
Frequently Asked Questions
Is there a standard BPC-157 dose everyone follows?
No. Because it is compounded and not FDA-approved, there is no single manufacturer dosing chart. Your provider sets a dose based on your history, goals, and how you respond, and that plan can look different from another patient's plan.
Will my provider change my dose over time?
Often, yes. Many providers revisit dosing after the first few weeks once they have more information, including your quarterly labs. This is a normal part of ongoing care rather than a sign anything went wrong.
Can I use a dose I found online?
No. A dose that suits someone else's history and goals may not be appropriate for yours. Ask your provider through messaging instead, and they can explain what fits your specific plan.
Do I need to mix the medication myself?
It depends on how your prescription is prepared. Your care team explains exactly what your vial requires. This article does not provide a mixing ratio because those details vary by prescription.
What if I want to combine BPC-157 with another peptide?
Mention it during your intake so your provider can evaluate your full picture. Combining protocols is a provider decision based on your history, not something to assemble on your own from general information.
How strong is the research behind BPC-157 dosing?
It is an early research area. Laboratory studies have explored a proposed mechanism, but there is not a large base of controlled human dosing trials. Your provider can speak candidly about what is and is not established.
telos rx is LegitScript-certified. Compounded medication is not FDA-approved and is prepared by partner compounding pharmacies. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.
Questions about dosing? Message the telos rx care team or start your evaluation at telos rx.